Acquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University

采购 Agilent Cytation C10 共焦成像阅读器,以提高克莱姆森大学的生物医学研究卓越性

基本信息

  • 批准号:
    10798537
  • 负责人:
  • 金额:
    $ 29.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-15 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Eukaryotic pathogens are the causative agents of some of the most devastating and intractable diseases of humans, including malaria, amebic dysentery, African sleeping sickness, Chagas disease, trichomoniasis, aspergillosis, cryptococcal fungal meningitis, toxoplasmosis and primary amebic meningoencephalitis (PAM). The global impact of these diseases is immense. It is noteworthy that many of these pathogens are the causative agents of neglected tropical diseases (NTDs), neglected diseases of poverty (NDPs) and/or are classified as bioterrorism agents. Importantly, infections caused by eukaryotic pathogens are increasing in the US due to globalization. The primary goal of this COBRE proposal is to increase the number of NIH-funded scientists in the state of South Carolina by supporting a world-class research center, the Eukaryotic Pathogens Innovation Center (EPIC), at Clemson University (CU). The scientific focus of EPIC is a multidisciplinary study of important global eukaryotic pathogens. EPIC is the first-and-only in the state with a focus on infectious diseases, and the first- and-only in the country with a focus on eukaryotic pathogens. Four projects from target junior investigators will be supported. Their projects are 1) Regulation mechanisms of Trypanosome brucei axonemal dynein, 2) Functional roles of ncRNA, afu-182, in azole response and pathobiology of Aspergillus fumigatus, 3) Investigating the function of macrophages in the efficacy of anti-fungal drugs in larval zebrafish, and 4) Evaluating anti-parasitic diazacyclobutenes. These investigators will be matched with external and internal mentors who are established NIH-funded researchers. The projects will be supported by a well-organized Administrative Core and two state-of-the-art Scientific Cores in Genomics, and Imaging/Cell Sorting. The center also has a substantial infrastructure base and significant institutional support. For example, CU will recruit two additional faculty members and two post-doctoral fellows to expand activities of this center over the course of the project period. Pledges of graduate assistantships, equipment, and space further exemplify the institutional commitment. The continuation of this COBRE-funded center will significantly expand research in South Carolina and will facilitate recruitment, training, and retention of a critical mass of investigators with cross-disciplinary skills in this important research area.
项目摘要/摘要 真核病原体是一些最具破坏性和最难治的疾病的病原体 人类,包括疟疾、阿米巴痢疾、非洲昏睡病、恰加斯病、滴虫病、 曲霉菌病、隐球菌性脑膜炎、弓形虫病和原发性阿米巴脑膜炎(PAM)。 这些疾病的全球影响是巨大的。值得注意的是,这些病原体中的许多都是 被忽视的热带病(NTDS)、被忽视的贫困疾病(NDP)和/或被忽视的疾病的病原体被分类为 生物恐怖主义特工。重要的是,由真核病原体引起的感染在美国正在增加,原因是 全球化。这项科布雷提案的主要目标是增加美国国立卫生研究院资助的科学家的数量 南卡罗来纳州通过支持世界级研究中心真核病原体创新中心 (EPIC),克莱姆森大学(CU)。EPIC的科学焦点是对重要的全球 真核病原体。EPIC是该州第一家也是唯一一家专注于传染病的公司,也是第一家- 而且--仅在该国,重点是真核病原体。来自目标初级调查人员的四个项目将 得到支持。他们的计划是:1)布氏锥虫轴膜动力蛋白的调节机制,2) NcRNA Afu-182在烟曲霉唑反应和病理生物学中的作用(3) 探讨巨噬细胞在斑马鱼幼体抗真菌药物疗效中的作用,以及4)评价 抗寄生的重氮环丁烯。这些调查人员将与符合以下条件的外部和内部导师相匹配 由美国国立卫生研究院资助的研究人员。这些项目将由一个组织良好的行政核心和 基因组学和成像/细胞分类领域的两个最先进的科学核心。该中心还拥有大量的 基础设施基础和重要的制度支持。例如,CU将额外招聘两名教职员工 成员和两名博士后研究员在项目期间扩大该中心的活动。 对研究生助学金、设备和空间的承诺进一步体现了机构承诺。这个 这个由科布雷资助的中心的继续下去将显著扩大南卡罗来纳州的研究,并将促进 招聘、培训和留住一批在这一重要领域具有跨学科技能的调查人员 研究领域。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Impact of fetal exposure to mycotoxins on longissimus muscle fiber hypertrophy and miRNA profile.
  • DOI:
    10.1186/s12864-022-08794-0
  • 发表时间:
    2022-08-16
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Greene, M. A.;Udoka, A. N. S.;Powell, R. R.;Noorai, R. E.;Bruce, T.;Duckett, S. K.
  • 通讯作者:
    Duckett, S. K.
Genetic Diversity and Fungicide Sensitivity of Cytospora plurivora on Peach.
桃多食胞孢菌的遗传多样性和杀菌剂敏感性。
  • DOI:
    10.1094/pdis-04-22-0790-re
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Baker,StephenT;Froelich,MarthaH;Boatwright,Harriet;Wang,Hehe;Schnabel,Guido;Kerrigan,Julia
  • 通讯作者:
    Kerrigan,Julia
Draft Genome Sequence of Exophiala Strain HKRS030, a Fungus Capable of Reducing Iron but Not Nitrate.
Venom phenotype conservation suggests integrated specialization in a lizard-eating snake.
  • DOI:
    10.1016/j.toxicon.2023.107135
  • 发表时间:
    2023-05
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tucker C. Heptinstall;Jason L. Strickland;R. A. Rosales-García;Rhett M. Rautsaw;Cassandra L. Simpson;G. Nystrom;S. A. Ellsworth;Michael P. Hogan;M. Borja;Pollyanna Fernandes Campos;F. Grazziotin;D. Rokyta;I. Junqueira-de-Azevedo;C. Parkinson
  • 通讯作者:
    Tucker C. Heptinstall;Jason L. Strickland;R. A. Rosales-García;Rhett M. Rautsaw;Cassandra L. Simpson;G. Nystrom;S. A. Ellsworth;Michael P. Hogan;M. Borja;Pollyanna Fernandes Campos;F. Grazziotin;D. Rokyta;I. Junqueira-de-Azevedo;C. Parkinson
Radiopaque Iodosilane-Coated Lipid Hybrid Nanoparticle Contrast Agent for Dual-Modality Ultrasound and X-ray Bioimaging.
  • DOI:
    10.1021/acsami.2c09104
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    9.5
  • 作者:
    M. Attia;R. Akasov;Nancy M. Elbaz;T. Owens;Evan C Curtis;Soham Panda;R. Santos-Oliveira;F. Alexis;Forrest M. Kievit;Daniel. C. Whitehead
  • 通讯作者:
    M. Attia;R. Akasov;Nancy M. Elbaz;T. Owens;Evan C Curtis;Soham Panda;R. Santos-Oliveira;F. Alexis;Forrest M. Kievit;Daniel. C. Whitehead
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES Culvin MORRIS其他文献

JAMES Culvin MORRIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES Culvin MORRIS', 18)}}的其他基金

Enolase inhibitors as therapeutic leads for Naegleria fowleri infections
烯醇酶抑制剂作为福氏耐格里阿米巴感染的治疗先导药物
  • 批准号:
    10739388
  • 财政年份:
    2023
  • 资助金额:
    $ 29.61万
  • 项目类别:
Approaches for genetic manipulation of Naegleria fowleri
福氏耐格里虫的基因操作方法
  • 批准号:
    10641130
  • 财政年份:
    2023
  • 资助金额:
    $ 29.61万
  • 项目类别:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
  • 批准号:
    10494462
  • 财政年份:
    2022
  • 资助金额:
    $ 29.61万
  • 项目类别:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
  • 批准号:
    10666653
  • 财政年份:
    2022
  • 资助金额:
    $ 29.61万
  • 项目类别:
Nutrient sensing and hexokinases in T. brucei
T. brucei 中的营养感应和己糖激酶
  • 批准号:
    7911534
  • 财政年份:
    2009
  • 资助金额:
    $ 29.61万
  • 项目类别:
Nutrient Sensing and Hexokinases in T. brucei
布氏锥虫的营养感应和己糖激酶
  • 批准号:
    8229951
  • 财政年份:
    2008
  • 资助金额:
    $ 29.61万
  • 项目类别:
Nutrient sensing and hexokinases in T. brucei
T. brucei 中的营养感应和己糖激酶
  • 批准号:
    7454845
  • 财政年份:
    2008
  • 资助金额:
    $ 29.61万
  • 项目类别:
Identification of Inhibitors of Trypanosoma Brucei Hexokinases
布氏锥虫己糖激酶抑制剂的鉴定
  • 批准号:
    7459260
  • 财政年份:
    2007
  • 资助金额:
    $ 29.61万
  • 项目类别:
Glucose Sensing and Hexokinases in the African Trypanosome
非洲锥虫中的葡萄糖传感和己糖激酶
  • 批准号:
    9900822
  • 财政年份:
  • 资助金额:
    $ 29.61万
  • 项目类别:
Glucose Sensing and Hexokinases in the African Trypanosome
非洲锥虫中的葡萄糖传感和己糖激酶
  • 批准号:
    9261578
  • 财政年份:
  • 资助金额:
    $ 29.61万
  • 项目类别:

相似海外基金

The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
  • 批准号:
    10511408
  • 财政年份:
    2022
  • 资助金额:
    $ 29.61万
  • 项目类别:
A One Health approach to investigating the ecology of East African trypanosomiasis in Malawian wildlife
调查马拉维野生动物中东非锥虫病生态学的“同一个健康”方法
  • 批准号:
    476178
  • 财政年份:
    2022
  • 资助金额:
    $ 29.61万
  • 项目类别:
    Studentship Programs
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
  • 批准号:
    10677879
  • 财政年份:
    2022
  • 资助金额:
    $ 29.61万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10466942
  • 财政年份:
    2021
  • 资助金额:
    $ 29.61万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10296873
  • 财政年份:
    2021
  • 资助金额:
    $ 29.61万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10706306
  • 财政年份:
    2021
  • 资助金额:
    $ 29.61万
  • 项目类别:
Reducing and replacing the animal cost of functional genetics in African trypanosomiasis
减少和替代非洲锥虫病功能遗传学的动物成本
  • 批准号:
    NC/W001144/1
  • 财政年份:
    2021
  • 资助金额:
    $ 29.61万
  • 项目类别:
    Research Grant
Development of new drug for African trypanosomiasis based on elucidation of the mechanism of antiprotozoal action by ribavirin.
基于利巴韦林抗原虫作用机制的阐明,开发治疗非洲锥虫病的新药。
  • 批准号:
    21K18230
  • 财政年份:
    2021
  • 资助金额:
    $ 29.61万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Development of a novel control measure for African trypanosomiasis based on the blocking of lifecycle progression
基于生命周期进展阻断的非洲锥虫病新型控制措施的开发
  • 批准号:
    20K07467
  • 财政年份:
    2020
  • 资助金额:
    $ 29.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Drug-diagnostic co-development in Tropical Medicine, combating Human African Trypanosomiasis
热带医学药物诊断联合开发,抗击非洲人类锥虫病
  • 批准号:
    18KK0454
  • 财政年份:
    2019
  • 资助金额:
    $ 29.61万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了